DPP-4 inhibitor
Dipeptidyl peptidase-4 inhibitor
- Weight neutral, low hypoglycemia risk
- Rare pancreatitis and joint pain
Drugs with this mechanism (5)
- Alogliptin — DPP-4 inhibitor for type 2 diabetes; weight-neutral but carries a heart-failure warning.
- Gemigliptin — DPP-4 inhibitor used for type 2 diabetes in some countries; weight-neutral with low hypoglycemia risk when used alone.
- Linagliptin — DPP-4 inhibitor for diabetes; uniquely non-renally cleared, no dose adjustment.
- Saxagliptin — DPP-4 inhibitor for diabetes; uniquely burdened by a heart-failure signal.
- Sitagliptin — The first DPP-4 inhibitor; weight-neutral, well tolerated.
All mechanisms · Open the interactive console ↗